Literature DB >> 7286589

Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States.

C F Garland, A M Lilienfeld, A I Mendeloff, J A Markowitz, K B Terrell, F C Garland.   

Abstract

A study was carried out during 1973 to determine the incidence of first hospitalizations for ulcerative colitis and Crohn's disease in 15 areas of the United States, including communities of widely varied size, climatic, ethnic, racial, and socioeconomic characteristics. The following descriptions apply to incidence rates per 100,000 population for the aggregate of the 15 areas. Ulcerative colitis had a bimodal age distribution in white males (with peaks at ages 20-29 and 70-79 yr) and females (with peaks at ages 30-39 and 70-79 yr). Crohn's disease had a bi- or trimodal age distribution in white males (with peaks at ages 20-29, 50-59, and 70-79 yr) and females (with peaks at ages 20-29, 50-59, and 70-79 yr). The age, sex, and geographic distributions that were observed in this study may have important etiologic implications.

Entities:  

Mesh:

Year:  1981        PMID: 7286589

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  38 in total

1.  A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.

Authors:  Atsushi Sakuraba; Toshiro Sato; Makoto Naganuma; Yuichi Morohoshi; Katsuyoshi Matsuoka; Nagamu Inoue; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

2.  Ulcerative proctitis in central Sweden 1965-1983. A population-based epidemiological study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

3.  Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa.

Authors:  S Shinozaki; T Nakamura; M Iimura; Y Kato; B Iizuka; M Kobayashi; N Hayashi
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease.

Authors:  J R Barton; S Gillon; A Ferguson
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

5.  Disability from inflammatory bowel disease among employees in West Germany.

Authors:  A Sonnenberg
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

6.  Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Authors:  Michael Wagner; Christer G B Peterson; Peter Ridefelt; Per Sangfelt; Marie Carlson
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

7.  Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.

Authors:  Y Raab; B Gerdin; S Ahlstedt; R Hällgren
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Epidemiology of Crohn's disease in Sicily: a hospital incidence study from 1987 to 1989. "The Sicilian Study Group of Inflammatory Bowel Disease".

Authors:  M Cottone; C Cipolla; A Orlando; L Oliva; R Aiala; A Puleo
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

9.  Crohn's disease in a Saudi outpatient population: is it still rare?

Authors:  Mohammad A Al-Mofarreh; Ibrahim A Al Mofleh; Ibrahim N Al-Teimi; Abdulrahman M Al-Jebreen
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

10.  Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.

Authors:  Yasushi Umehara; Masatoshi Kudo; Masanori Kawasaki
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.